Mohemmed Nazir Khan, MD Email Mohemmed Khan
- ASSISTANT PROFESSOR | Otolaryngology
- Ear, Nose, Throat / Otolaryngology
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside and Mount Sinai West
- New York Eye and Ear Infirmary of Mount Sinai
- The Mount Sinai Hospital
- Mount Sinai Union Square 212-844-8775 212-844-8775
Dr. Nazir Khan is an Assistant Professor in the Department of Otolaryngology at Mount Sinai Union Square, and Associate Director of the Head and Neck Cancer Research Program at the Icahn School of Medicine at Mount Sinai. He received his medical degree from the Rutgers – New Jersey Medical School and completed his residency in Otolaryngology - Head and Neck Surgery at the Icahn School of Medicine. Subsequently, he completed fellowship training in Head and Neck Oncology and Microvascular Reconstruction at the University of Toronto.
His clinical interests and expertise include the medical and surgical management of benign head and neck tumors; thyroid and parathyroid disorders; salivary gland disorders; head and neck cancers; and reconstructive surgery involving the head and neck. Dr. Khan’s research interests encompass functional and long-term survival outcomes of patients with advanced head and neck cancers undergoing varying treatment modalities. He has co-authored numerous textbook chapters and published manuscripts in peer-reviewed journals in otolaryngology and neurosurgery.
Dr. Khan is available for rapid referrals and same day appointments.
- Esophageal Cancer
- Head and Neck Squamous cell cancer
- Laryngeal Cancer
- Lymph Node Biopsy
- Maxillofacial Cancer
- Melanoma Removal
- Neck Lump(s)
- Nontoxic Nodular Goiter
- Parathyroid Disorder
- Robot-Assisted Surgery - Overview
- Skin Cancer
- Skin Graft
- Soft Tissue Sarcoma
- Throat Cancer
- Thyroid Cancer
- Tongue Cancer
- Tonsil Cancer
Fellowship, Head & Neck/Microvascular Reconstruction
University of Toronto
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Khan did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.